¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå
Single Photon Emission Computed Tomography (SPECT)
»óǰÄÚµå : 1760821
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 469 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,068,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,204,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ¼¼°è ½ÃÀåÀº 2030³â±îÁö 33¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 22¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 7.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 33¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½ÉÀ庴ÇÐÀº CAGR 8.1%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 13¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¾¾çÇÐ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 7.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 9,000¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀåÀº 2024³â¿¡ 7¾ï 9,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 3¾ï 9,860¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.7%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 5.8%¿Í 6.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.7%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT)Àº ÇÙÀÇÇÐ ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ´Â ÷´Ü ¿µ»ó ±â¼úÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ¹æ»ç¼º ÃßÀûÀÚ¿¡¼­ ¹æÃâµÇ´Â °¨¸¶¼±À» °¨ÁöÇÏ¿© ü³»ÀÇ ´ë»ç ¹× »ý¸®Àû °úÁ¤À» 3Â÷¿øÀûÀ¸·Î ½Ã°¢È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃßÀûÀÚ´Â ÀϹÝÀûÀ¸·Î Ç÷·ù¿¡ ÁÖÀԵǸç, »ç¿ëµÈ ÃßÀûÀÚÀÇ À¯Çü¿¡ µû¶ó ƯÁ¤ Á¶Á÷, Àå±â ¶Ç´Â ¼¼Æ÷ ¼ö¿ëü¿¡ ÃàÀûµË´Ï´Ù. SPECT´Â ½ÉÀåÇÐ, Á¾¾çÇÐ, ½Å°æÇп¡¼­ ƯÈ÷ À¯¿ëÇϸç, °ü»óµ¿¸Æ Áúȯ, Á¾¾ç, °£Áú ¹× ¾ËÃ÷ÇÏÀ̸Ӻ´°ú °°Àº ½Å°æ Áúȯ°ú °°Àº Áúȯ¿¡ ´ëÇÑ Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. SPECTÀÇ ±â´ÉÀû ¿µ»óÁø´Ü ´É·ÂÀº ÁÖ·Î ÇØºÎÇÐÀû Á¤º¸¸¦ Á¦°øÇÏ´Â CT³ª MRI¿Í °°Àº ´Ù¸¥ ¿µ»óÁø´Ü¹ý°ú Â÷º°È­µË´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº SPECTÀÇ ´É·Â°ú ÀÀ¿ëÀ» Å©°Ô Çâ»ó½ÃÄ×À¸¸ç, SPECT¿Í ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT/CT)ÀÇ ÅëÇÕÀº ±â´ÉÀû ¿µ»ó°ú ÇØºÎÇÐÀû ¿µ»óÀ» ÇÑ ¹øÀÇ ¼¼¼Ç¿¡¼­ °áÇÕÇÏ¿© ÀÌ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÌ ÇÏÀ̺긮µå Á¢±Ù¹ýÀº Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ã۰í, ÀÌ»ó ºÎÀ§ÀÇ ±¹¼ÒÈ­¿Í Ư¡À» º¸´Ù ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Ä«µå¹Å-¾Æ¿¬ Ä«µå¹Å ÅÚ·ê¶óÀ̵å(CZT) °ËÃâ±â »ç¿ë°ú °°Àº ÃÖ±Ù °ËÃâ±â ±â¼ú °³¹ß µ¿ÇâÀº SPECT ½Ã½ºÅÛÀÇ °¨µµ¿Í ÇØ»óµµ¸¦ Çâ»ó½ÃÄÑ ÃÔ¿µ ½Ã°£À» ´ÜÃàÇϰí ȯÀÚÀÇ ÇÇÆø¼±·®À» °¨¼Ò½Ãų ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¿µ»ó À籸¼º ¹× ¿µ»ó 󸮸¦ À§ÇÑ ¼ÒÇÁÆ®¿þ¾î ¾Ë°í¸®ÁòÀÇ ¹ßÀüÀ¸·Î SPECT ¿µ»óÀÇ Ç°Áú°ú Á¤·®Àû Á¤È®µµ°¡ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î SPECT´Â ÀÓ»ó°ú ¿¬±¸ ¾ç¸é¿¡¼­ À¯¿ë¼ºÀÌ È®´ëµÇ¾î Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù.

SPECT ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ, ¾Ï, ½Å°æ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Áø´Ü ¹× °ü¸®¸¦ À§ÇØ »ó¼¼ÇÑ ±â´ÉÀû ¿µ»óÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÏÀ̺긮µå SPECT/CT ½Ã½ºÅÛÀÇ °³¹ß, °ËÃâ±â Àç·á ¹× ¿µ»óó¸® ¾Ë°í¸®ÁòÀÇ °³¼±À» Æ÷ÇÔÇÑ ±â¼úÀû ¹ßÀüÀº SPECTÀÇ ÀÓ»óÀû À¯¿ë¼º°ú º¸±ÞÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á°¡ °­Á¶µÇ¸é¼­ ȯÀÚ °³°³Àο¡ ¸Â´Â Ä¡·á¸¦ À§ÇÑ Á¤È®ÇÑ Áø´Ü µµ±¸ÀÇ Çʿ伺ÀÌ SPECT¿Í °°Àº °í±Þ ¿µ»ó Áø´Ü ¾ç½Ä¿¡ ´ëÇÑ ¼ö¿ä¸¦ ºÎÃß±â°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ¿¡ Ãë¾àÇÑ ³ë·ÉÀα¸ Áõ°¡´Â SPECTÀÇ ÀáÀçÀû ½ÃÀåÀ» ´õ¿í È®´ë½Ã۰í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ¹æ»ç¼ºÀǾàǰÀÇ °¡¿ë¼º Áõ°¡¿Í Àü ¼¼°è ÇÙÀÇÇÐ ½Ã¼³ÀÇ È®´ëµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ SPECT ½ÃÀåÀÇ ¿ªµ¿ÀûÀÌ°í ¹ßÀüÀûÀΠƯ¼ºÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(½ºÅĵå¾ó·Ð, ÇÏÀ̺긮µå), ¿ëµµ(½ÉÀ庴ÇÐ, Á¾¾çÇÐ, ½Å°æÇÐ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø, Áø´Ü¼¾ÅÍ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 45°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Single Photon Emission Computed Tomography (SPECT) Market to Reach US$3.3 Billion by 2030

The global market for Single Photon Emission Computed Tomography (SPECT) estimated at US$2.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cardiology, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Oncology segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$790.0 Million While China is Forecast to Grow at 9.7% CAGR

The Single Photon Emission Computed Tomography (SPECT) market in the U.S. is estimated at US$790.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$398.6 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Single Photon Emission Computed Tomography (SPECT) Market - Key Trends & Drivers Summarized

Single Photon Emission Computed Tomography (SPECT) is a sophisticated imaging technique widely used in the field of nuclear medicine. This modality allows for three-dimensional visualization of metabolic and physiological processes in the body by detecting gamma rays emitted from radioactive tracers. These tracers are typically injected into the bloodstream and accumulate in specific tissues, organs, or cellular receptors, depending on the type of tracer used. SPECT is particularly valuable in cardiology, oncology, and neurology, providing critical insights into conditions such as coronary artery disease, tumors, and neurological disorders like epilepsy and Alzheimer's disease. The ability of SPECT to provide functional imaging distinguishes it from other imaging modalities like CT and MRI, which primarily offer anatomical information.

Technological advancements have significantly enhanced the capabilities and applications of SPECT. The integration of SPECT with computed tomography (SPECT/CT) has revolutionized the field by combining functional and anatomical imaging in a single session. This hybrid approach improves diagnostic accuracy and allows for better localization and characterization of abnormalities. Recent developments in detector technology, such as the use of cadmium zinc telluride (CZT) detectors, have increased the sensitivity and resolution of SPECT systems, enabling faster acquisition times and reduced radiation doses for patients. Furthermore, advancements in software algorithms for image reconstruction and processing have improved the quality and quantitative accuracy of SPECT images. These innovations have expanded the utility of SPECT in both clinical practice and research, making it an indispensable tool in modern healthcare.

The growth in the SPECT market is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders is a major driver, as these conditions often require detailed functional imaging for diagnosis and management. Technological advancements, including the development of hybrid SPECT/CT systems and improvements in detector materials and image processing algorithms, have significantly enhanced the clinical utility and adoption of SPECT. Additionally, the growing emphasis on personalized medicine and the need for precise diagnostic tools to tailor treatments to individual patients are fueling demand for advanced imaging modalities like SPECT. The rising geriatric population, which is more susceptible to chronic diseases, further expands the potential market for SPECT. Lastly, the increasing availability of radiopharmaceuticals and the expansion of nuclear medicine facilities worldwide are also contributing to market growth. These factors collectively underscore the dynamic and evolving nature of the SPECT market.

SCOPE OF STUDY:

The report analyzes the Single Photon Emission Computed Tomography (SPECT) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Standalone, Hybrid); Application (Cardiology, Oncology, Neurology, Other Applications); End-Use (Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 45 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â